Hepatitis C Virus
Hepatitis C virus is not prevalent in liver transplant surgeons
Published in Hepatitis Weekly, August 28th, 2006
"The risk of HCV transmission to surgeons is related to the HCV prevalence in the surgical patient population. As HCV-related cirrhosis is the commonest indication for liver transplantation in Europe and North America, liver transplant surgeons are at particular risk.
"The prevalence of HCV infection in liver transplant surgeons is unknown. The aim of this study was to estimate the prevalence of HCV infection in liver transplant surgeons attending the 9th Congress of the International Liver Transplantation Society...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-08-28)
More Articles from Hepatitis Weekly
- Hepatitis B Genetics
Hepatitis B virus precore mutations are associated with liver disease severity - Hepatitis C Virus
Hepatitis C virus entry depends on clathrin-mediated endocytosis - Hepatitis D Virus
Molecular dynamics of the hepatitis delta virus ribozyme elucidated - Hepatosteatosis & Hepatitis
Hepatosteatosis T helper response is associated with enhanced mediated hepatitis - Liver Transplantation
Dendritic cell decrease could favor post-liver transplant hepatitis C virus recurrence - Adverse Drug Reaction
Pharmacokinetics of telbivudine in healthy subjects clarified - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
